Centessa Pharmaceuticals (CNTA) Debt Ratio (2020 - 2026)

Centessa Pharmaceuticals (CNTA) has 7 years of Debt Ratio data on file, last reported at 0.17 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.17, down 16.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.17 (down 16.86% YoY), and the FY2025 annual result was 0.16, down 15.21% from the prior year.
• Debt Ratio improved to 0.17 in Q1 2026 per CNTA's latest filing, from 0.16 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.24 in Q3 2025 and troughed at 0.12 in Q3 2024.
• A 5-year average of 0.18 and a median of 0.19 in 2023 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio slumped 36.69% in 2024, then soared 97.3% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.16 in 2022, then surged by 33.76% to 0.21 in 2023, then declined by 10.12% to 0.19 in 2024, then slipped by 15.21% to 0.16 in 2025, then gained by 7.46% to 0.17 in 2026.
• Business Quant data shows CNTA's Debt Ratio at 0.17 in Q1 2026, 0.16 in Q4 2025, and 0.24 in Q3 2025.